At the intersection of longevity and precision medicine, Humlab Global is redefining how we address the biological decline of aging. Rather than relying on standard murine studies that often fail to translate to clinical success, the company utilizes humanized mouse models—specialized systems where human immune components or tissues are integrated into biological frameworks. This allows their researchers to observe the efficacy of senolytic therapies and metabolic interventions in a context that mirrors human physiology. By narrowing the gap between the lab bench and the clinic, Humlab Global aims to shift the focus from merely extending lifespan to significantly expanding "healthspan," the period of life spent free from chronic disease.